Latest filing published 04 Dec 2019 for Oasmia Pharmaceutical AB, €2,441.
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Nina Heldring: trading record in brief
All filings by Nina Heldring on record concern Oasmia Pharmaceutical AB. Activity is concentrated on a single trading day, 29 November 2019, with 2 filings.
Purchases make up the whole of the open-market record (2 purchases, €4,738). Unlike grants, an open-market purchase is paid for by the insider, at the market price.
The record was last updated on 4 December 2019 with an open-market purchase (€2,441) in Oasmia Pharmaceutical AB. These figures are compiled from regulatory filings published by Finansinspektionen. They describe what insiders did and are not a recommendation.
Companies and markets linked to Nina Heldring
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 15,105 shares@ SEK 1.7051.5% of flowTeckningsrättISIN SE0013460540FI:csv-5cf069200eaf90a41defCanonical exit: 27 Feb 2020 (T+90)
- 12,084 shares@ SEK 2.0048.5% of flowBTA (betald tecknad aktie)ISIN SE0002941799FI:csv-c245f42db245cda6bc8bCanonical exit: 27 Feb 2020 (T+90)
2 of 2 declarations